Novavax, Inc. - Common Stock (NQ:NVAX)

10.46 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

68 69 Next >

Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today? ↗

October 03, 2023

U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%.

Via Benzinga

Topics Government Stocks

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna ↗

October 03, 2023

The company can now join Pfizer and Moderna in launching an updated booster in the U.S.

Via Investor's Business Daily

Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? ↗

October 03, 2023

Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.

Via Benzinga

Why Pfizer and BioNTech Stocks Zoomed Higher Today ↗

September 29, 2023

The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.

Via The Motley Fool

NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month ↗

September 28, 2023

With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits.

Via InvestorPlace

Topics Artificial Intelligence

Up 20% in 1 Month, Is This Stock a Buy? ↗

September 13, 2023

As Covid cases rise, Novavax is getting more attention again. But will the momentum last?

Via The Motley Fool

Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done ↗

September 26, 2023

Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks.

Via InvestorPlace

Does This Message From Moderna Mean Bad News for Novavax? ↗

September 21, 2023

So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market.

Via The Motley Fool

You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10 ↗

September 19, 2023

These stocks look cheap right now -- if the companies can meet their goals.

Via The Motley Fool

Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now? ↗

September 18, 2023

When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to...

Via Benzinga

More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone ↗

September 15, 2023

New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...

Via Benzinga

Why COVID Vaccine Demand Might Not Be That Strong ↗

September 14, 2023

COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago.

Via The Motley Fool

Novavax Is a Step Behind, Again. Should You Be Worried? ↗

September 14, 2023

The FDA still is reviewing Novavax's updated vaccine candidate.

Via The Motley Fool

DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories ↗

September 12, 2023

Benzinga

Via Benzinga

Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today ↗

September 11, 2023

U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday.

Via Benzinga

Topics Stocks

Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits ↗

September 11, 2023

The U.S.

Via Benzinga

Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters ↗

September 11, 2023

Novavax says it's working with the FDA to answer final requests as part of the agency's review.

Via Investor's Business Daily

7 Biotech Stocks to Sell in September Before They Crash & Burn ↗

September 06, 2023

These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues.

Via InvestorPlace

Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry ↗

September 06, 2023

On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the...

Via Benzinga

Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant ↗

September 06, 2023

Pirola has about 30 mutations compared with previous omicron versions of the virus.

Via Investor's Business Daily

This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock? ↗

September 06, 2023

Today, Novavax is getting ready to compete in the fall vaccine market -- one that's in transition.

Via The Motley Fool

Novavax, Zscaler, Digital Brands Group, Asana, Tesla: Why These 5 Stocks Are Drawing Investor Attention Today ↗

September 05, 2023

Via Benzinga

Why Novavax Stock Rocketed 10% Higher Today ↗

September 05, 2023

The COVID vaccine maker benefits on a day when worries about a surge intensify with a new case at the White House.

Via The Motley Fool

Why Novavax Stock Traded Higher Today ↗

September 05, 2023

Novavax, Inc. (NASDAQ: NVAX) shares trader higher Tuesday amid rising COVID cases in the US, which has lifted vaccine stocks in recent weeks.

Via Benzinga

Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks? ↗

September 05, 2023

Investors have worried about vaccine revenue in a post-pandemic world.

Via The Motley Fool

2 Stocks That Doubled EPS Estimates and Flashing Buy Signals

September 01, 2023

The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with

Via MarketBeat

7 Undervalued Stocks Due for a Massive Short Squeeze ↗

September 01, 2023

These are the undervalued short squeeze candidates and these stocks represent fundamentally strong growth companies

Via InvestorPlace

3 Biotech Stocks Due for a Massive Short Squeeze ↗

August 31, 2023

These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters.

Via InvestorPlace

Should You Buy Novavax's Stock Before the FDA Approves Its New COVID Shot? ↗

August 31, 2023

The vaccine's approval could come within weeks.

Via The Motley Fool

3 of Wall Street’s Most Shorted Stocks Due for a Massive Short Squeeze ↗

August 30, 2023

These are the most shorted stocks trading in the U.S. stock market, and any good news could put their short sellers into a serious bind.

Via InvestorPlace

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.